PT - JOURNAL ARTICLE AU - Tang, Jinsong AU - Wu, Qiuxia AU - Qi, Chang AU - Xie, An AU - Liu, Jianbin AU - Sun, Yunkai AU - Yuan, Tifei AU - Chen, Wei AU - Liu, Tieqiao AU - Hao, Wei AU - Liao, Yanhui TI - Widespread Cortical Thickness Reductions Following Non-medical Use of Ketamine: a Structural MRI Study of Individuals with Ketamine Dependence AID - 10.1101/2021.02.21.21252178 DP - 2021 Jan 01 TA - medRxiv PG - 2021.02.21.21252178 4099 - http://medrxiv.org/content/early/2021/02/23/2021.02.21.21252178.short 4100 - http://medrxiv.org/content/early/2021/02/23/2021.02.21.21252178.full AB - Background A version of ketamine, called Esketamine has been approved for treatment-resistant depression (TRD). Ketamine (“K powder”), a “dissociative” anesthetic agent, however, has been used non-medically alone or with other illicit substances. Our previous studies showed a link between non-medical ketamine use and brain structural and functional alterations. We found dorsal prefrontal gray matter reduction in chronic ketamine users. It is unknown, however, whether these observations might parallel findings of cortical thickness alterations. This study aimed at exploring cortical thickness abnormalities following non-medical, long-term use of ketamine.Methods Structural brain images were acquired for 95 patients with ketamine dependence, and 169 drug-free healthy controls. FreeSurfer software was used to measure cortical thickness for 68 brain regions. Cortical thickness was compared between the two groups using analysis of covariance (ANCOVA) with covariates of age, gender, educational level, smoking, drinking, and whole brain mean cortical thickness. Results were considered significant if the Bonferroni corrected P-value < 0.01.Results Compared to healthy controls, patients with ketamine dependence have widespread decreased cortical thickness, with the most extensive reductions in the frontal (including the dorsolateral prefrontal cortex, DLPFC) and parietal (including the precuneus) lobes. Increased cortical thickness was not observed in ketamine users relative to comparison subjects. Estimated total lifetime ketamine consumption is correlated with the right inferior parietal and the right rostral middle frontal cortical thickness reductions.Conclusions This study provides first evidence that, compared with healthy controls, chronic ketamine users had cortical thickness reductions.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was supported by the National Natural Science Foundation of China (grant no. 81871057 to JT, 81671324 to TL and 81671325 to YL), and the Hunan Provincial Natural Science Foundation of China (grant no. 2020JJ4794 to YL and 2020JJ4795 to TL), and by the Hundred Talents Program funding from Zhejiang University. The funders had no role in study design, data collection and analysis, decision to write the report or to submit the paper for publication.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Each study sample was collected with subjects written informed consent approved by the Ethics Committee of the Second Xiangya Hospital, Central South University (No. S163, 2011). The authors assert that all procedures contributing to this work were carried out in accordance with the Helsinki Declaration of 1975, as revised in 2008.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData will be available by request.